NSPR — InspireMD Balance Sheet
0.000.00%
- $62.21m
- $28.26m
- $6.21m
- 33
- 15
- 67
- 32
Annual balance sheet for InspireMD, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.51 | 12.6 | 34 | 17.8 | 39 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.973 | 0.945 | 1.39 | 1.25 | 2.45 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 7.81 | 15.3 | 37.1 | 21.3 | 44.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.48 | 1.71 | 1.71 | 2.47 | 2.53 |
Other Long Term Assets | |||||
Total Assets | 9.88 | 17.8 | 39.7 | 24.7 | 47.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.12 | 3.71 | 4.35 | 5.07 | 6.02 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.5 | 5.61 | 6.18 | 7.26 | 8.14 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 5.38 | 12.2 | 33.5 | 17.4 | 39.5 |
Total Liabilities & Shareholders' Equity | 9.88 | 17.8 | 39.7 | 24.7 | 47.6 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |